Parker Institute For Cancer Immunotherapy

Organization Overview

Parker Institute For Cancer Immunotherapy is located in San Francisco, CA. The organization was established in 2015. According to its NTEE Classification (E12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Health Care and related organizations. As of 12/2021, Parker Institute For Cancer Immunotherapy employed 113 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Parker Institute For Cancer Immunotherapy is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.

For the year ending 12/2021, Parker Institute For Cancer Immunotherapy generated $171.0m in total revenue. This organization has experienced exceptional growth, as over the past 7 years, it has increased revenue by an average of 12.8% each year . All expenses for the organization totaled $52.6m during the year ending 12/2021. You can explore the organizations financials more deeply in the financial statements section below.

Since 2015, Parker Institute For Cancer Immunotherapy has awarded 85 individual grants totaling $221,495,851. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.

Mission & Program ActivityExcerpts From the 990T Filing

TAX YEAR

2021

Describe the Organization's Mission:

Part 3 - Line 1

SEE SCHEDULE O

Describe the Organization's Program Activity:

PICI ENCOURAGES ADVANCES IN CANCER IMMUNOTHERAPY RESEARCH, COLLABORATION, AND DISCOVERY, AND THE TRANSLATION OF THESE ADVANCES INTO CURES AND TREATMENTS FOR THE BENEFIT OF PATIENTS. TO DO THIS, PICI CONDUCTS ITS OWN RESEARCH AND CLINICAL TRIALS AND PROVIDES ITS CONSORTIUM OF PREEMINENT HOSPITALS AND ACADEMIC RESEARCH CENTERS WITH SHARED RESEARCH RESOURCES, SUCH AS SCIENTIFIC EQUIPMENT, CONSUMABLES, BIOINFORMATICS ANALYSIS, AND A SPECIMEN BIOBANK. PICI ALSO FUNDS AND OTHERWISE SUPPORTS CANCER IMMUNOTHERAPY RESEARCH WITHIN ITS CONSORTIUM.


Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.

Outside Vendors & Contractors

Vendor Name (Service)Compensation
Rosewood Miramar Resort
Conference Facilitie
$1,637,706
Xcancer Llc
Biobanking & Sample
$1,209,238
Aris Clinical Inc
Clinical Trial Monit
$686,955
Spencer Stuart
Recruiting
$594,000
Azenta-brooks Life Sciences
Biostorage & Sample
$591,720
View All Vendors

Financial Statements

Statement of Revenue
Federated campaigns$0
Membership dues$0
Fundraising events$0
Related organizations$0
Government grants $0
All other contributions, gifts, grants, and similar amounts not included above$160,955,548
Noncash contributions included in lines 1a–1f $9,865,548
Total Revenue from Contributions, Gifts, Grants & Similar$160,955,548
Total Program Service Revenue$9,757,426
Investment income $94,889
Tax Exempt Bond Proceeds $0
Royalties $188,327
Net Rental Income $0
Net Gain/Loss on Asset Sales $0
Net Income from Fundraising Events $0
Net Income from Gaming Activities $0
Net Income from Sales of Inventory $0
Miscellaneous Revenue$0
Total Revenue $170,996,190

Grants Awarded

Over the last fiscal year, Parker Institute For Cancer Immunotherapy has awarded $9,050,382 in support to 15 organizations.

Grant RecipientAmount

STANFORD UNIVERSITY

Org PageRecipient Profile

Redwood City, CA

PURPOSE: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY

$2,768,011

DANA-FARBER CANCER INSTITUTE INC

Org PageRecipient Profile

Boston, MA

PURPOSE: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY

$1,500,000

MEMORIAL SLOAN KETTERING CANCER CENTER

Org PageRecipient Profile

New York, NY

PURPOSE: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY

$797,242

REGENTS OF UNIVERSITY OF CALIFORNIA SAN FRANCISCO

Org PageRecipient Profile

San Francisco, CA

PURPOSE: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY

$574,028

UNIVERSITY OF CALIFORNIA LOS ANGELES

Org PageRecipient Profile

Los Angeles, CA

PURPOSE: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY

$572,590

WEILL CORNELL MEDICINE

PURPOSE: SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY

$495,462
View Grant Profile

Grants Recieved

Over the last fiscal year, we have identified 7 grants that Parker Institute For Cancer Immunotherapy has recieved totaling $152,140,314.

Awarding OrganizationAmount
Silicon Valley Community Foundation

Mountain View, CA

PURPOSE: Health

$150,500,000
Leona M & Harry B Helmsley Charitable Trust

New York, NY

PURPOSE: STUDYING AUTOIMMUNE DIABETES FOLLOWING CERTAIN CANCER IMMUNOTHERAPIES.

$750,000
Cancer Research Institute Inc

New York, NY

PURPOSE: RESEARCH

$519,995
Leona M & Harry B Helmsley Charitable Trust

New York, NY

PURPOSE: STUDYING AUTOIMMUNE DIABETES FOLLOWING CERTAIN CANCER IMMUNOTHERAPIES.

$358,140
Schwab Charitable Fund

San Francisco, CA

PURPOSE: HEALTH

$11,000
Pfizer Foundation Inc

New York, NY

PURPOSE: MATCHING GIFTS

$1,000
View Grant Recipient Profile

Create an account to unlock the data you need.

or